Indeed, we observed that homozygous loss of RB1 correlates with higher expression of ACSL4 in the data sets of metastatic castration-resistant prostate cancer (Figure 2, M and N, and Supplemental Figure 4A). The gene discussed is ACSL4; the disease is prostate cancer.